Finance

Lists
SRTA:NASDAQ
Strata Critical Medical Inc
4,68 USD
-1,47%
(-0,070) 1D
4,68 USD
0,00% (0,00)
After hours
Closed: 7-окт., 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SRTA...
Open
4,74 USD
High
4,74 USD
Low
4,65 USD
Mkt. cap
414,02 млн
Avg. vol.
821,54 миң
Volume
0,00
P/E ratio
9,47
52-wk high
6,50 USD
52-wk low
3,95 USD
EPS
0,49 USD
Beta
2,43
Shares outstanding
88,47 млн
No. of employees
327
Open
4,74 USD
High
4,74 USD
Low
4,65 USD
Mkt. cap
414,02 млн
Avg. vol.
821,54 миң
Volume
0,00
P/E ratio
9,47
52-wk high
6,50 USD
52-wk low
3,95 USD
EPS
0,49 USD
Beta
2,43
Shares outstanding
88,47 млн
No. of employees
327
News stories
From web sources and news partners
About Strata Critical Medical Inc
CEO-
Employees327
Founded2014
Headquarters-
SectorHealth care provider
Analyst ratings
Based on 1 analyst giving stock ratings to SRTA in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for SRTA in the last 3 months
Highest
Current 4,68 USD
9,50 USD (+102,99%)
Average
9,50 USD (+102,99%)
Lowest
9,50 USD (+102,99%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ben Haynor
Lake Street
Buy
Reiterated
9,50 USD
+103%
08/05/2026
William Bonello
Craig-Hallum
Buy
Maintained
-
-
06/26/2026
Jon Hickman
Ladenburg Thalmann & Co.
Buy
Reiterated
11,50 USD
+145,7%
05/07/2026
Yuan Zhi
B. Riley Securities
Buy
Initiated
8,00 USD
+70,9%
03/25/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
49,30 млн
66,79 млн
67,38 млн
72,51 млн
Cost of goods sold
37,68 млн
55,12 млн
53,27 млн
57,29 млн
Cost of revenue
37,68 млн
55,12 млн
53,27 млн
57,29 млн
Research and development expenses
453,00 миң
-1,35 млн
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
11,74 млн
13,99 млн
14,54 млн
13,17 млн
Operating expense
12,19 млн
15,24 млн
16,02 млн
19,80 млн
Total operating expenses
49,88 млн
70,35 млн
69,29 млн
77,09 млн
Operating income
-577,00 миң
-3,57 млн
-1,90 млн
-4,58 млн
Other non operating income
33,00 миң
1,42 млн
1,46 млн
71,00 миң
EBT including unusual items
-9,66 млн
-5,39 млн
2,40 млн
-10,52 млн
EBT excluding unusual items
583,00 миң
-1,51 млн
27,00 миң
-4,18 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
57,42 млн
-8,83 млн
2,15 млн
-10,52 млн
Net profit margin
116,47%
-13,23%
3,20%
-14,50%
Earnings per share
-
-
0,04
-
Interest and investment income
1,13 млн
638,00 миң
473,00 миң
331,00 миң
Interest expense
-
-
-
-
Net interest expenses
1,13 млн
638,00 миң
473,00 миң
331,00 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
-158,00 миң
-558,00 миң
1,16 млн
3,93 млн
Gain or loss from assets sale
-60,44 млн
-
344,00 миң
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google колдонмолору